Citigroup’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Citigroup’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-47,030	Closed	-$8.13M	–	8116
2015 Q1	$8.13M	Buy	47,030 +14,015	+42%	+$2.06M	0.01%	1349
2014 Q4	$3.79M	Buy	33,015 +24,534	+289%	+$2.97M	﹤0.01%	1995
2014 Q3	$1.32M	Sell	8,481 -2,524	-23%	-$366K	﹤0.01%	2848
2014 Q2	$1.36M	Buy	11,005 +4,261	+63%	+$471K	﹤0.01%	2747
2014 Q1	$698K	Sell	6,744 -19,491	-74%	-$2M	﹤0.01%	3190
2013 Q4	$2.36M	Sell	26,235 -9,501	-27%	-$758K	﹤0.01%	2416
2013 Q3	$2.39M	Buy	35,736 +28,909	+423%	+$1.99M	﹤0.01%	2341
2013 Q2	$451K	Buy	+6,827	New	+$390K	﹤0.01%	3581

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Citigroup's SLXP Position: Q2 2015 in Review

Citigroup sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 47,030 shares — an estimated $8.13M sold.

Citigroup first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $8.13M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Citigroup reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Citigroup sold 47,030 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $8.13M.
Citigroup first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Citigroup's SALIX PHARMACEUTICALS LTD DEL position peaked at $8.13M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Citigroup's 13F filing for Q2 2015, filed 13 Aug 2015.